Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
Several start-up companies have been actively engaged in this flourishing field of drug research and development in recent years. They have successively gained the breakthrough therapy designation from the FDA or carried out IPOs. The following are four notable biotechnology companies around the world: Compass Pathways, Atai Life Sciences, MindMed, and Cybin.
It's free! Log in now to read